| Literature DB >> 35595747 |
Fabiola Forteza1,2, Isabelle Bourdeau-Julien1,2, Guillaume Q Nguyen1,2, Fredy Alexander Guevara Agudelo1,2, Gabrielle Rochefort1,2, Lydiane Parent1,2, Volatiana Rakotoarivelo3,2, Perrine Feutry1, Cyril Martin3,2, Julie Perron1,2, Benoît Lamarche1,4, Nicolas Flamand3,5,2, Alain Veilleux1,4,2, François Billaut6, Vincenzo Di Marzo1,3,4,5,7,2, Frédéric Raymond8,9,10.
Abstract
The extended endocannabinoid system, also termed endocannabinoidome, participates in multiple metabolic functions in health and disease. Physical activity can both have an acute and chronic impact on endocannabinoid mediators, as does diet. In this crossover randomized controlled study, we investigated the influence of diet on the peripheral response to acute maximal aerobic exercise in a sample of active adult women (n = 7) with no underlying metabolic conditions. We compared the impact of 7-day standardized Mediterranean diet (MedDiet) and control diet inspired by Canadian macronutrient intake (CanDiet) on endocannabinoidome and short-chain fatty acid metabolites post maximal aerobic exercise. Overall, plasmatic endocannabinoids, their congeners and some polyunsaturated fatty acids increased significantly post maximal aerobic exercise upon cessation of exercise and recovered their initial values within 1 h after exercise. Most N-acylethanolamines and polyunsaturated fatty acids increased directly after exercise when the participants had consumed the MedDiet, but not when they had consumed the CanDiet. This impact was different for monoacylglycerol endocannabinoid congeners, which in most cases reacted similarly to acute exercise while on the MedDiet or the CanDiet. Fecal microbiota was only minimally affected by the diet in this cohort. This study demonstrates that endocannabinoidome mediators respond to acute maximal aerobic exercise in a way that is dependent on the diet consumed in the week prior to exercise.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35595747 PMCID: PMC9122896 DOI: 10.1038/s41598-022-10757-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Initial characteristics of subjects (n = 7).
| Mean ± SD | Range | |
|---|---|---|
| Age (yr) | 25 ± 5 | 19–32 |
| BMI (kg/m2) | 22.52 ± 1.57 | 19.50–24.49 |
| Waist circumference (cm) | 78.32 ± 5.54 | 68.50–85.67 |
| Energetic need (kcal/jr) | 2306.1 ± 310.8 | 1822.0–2853.0 |
| Heart rate at rest (bpm) | 61 ± 12 | 48–83 |
| Physical activity (min/week) | 473 ± 162 | 225–720 |
Figure 1Schematic representation of the randomized crossover format of the study and the process from the start to the end including the periods of restricted diet, aerobic tests, samples taken and analyses performed.
Macronutrients and micronutrients composition of the CanDiet and the MedDiet.
| CanDiet | MedDiet | |
|---|---|---|
| Energy (KCAL) | 2485 | 2502 |
| HEI score | 57.2 | 86.4 |
| Carbohydrates (%E) | 51.77 | 50.64 |
| Proteins (%E) | 16.88 | 16.68 |
| Lipids (%E) | 31.16 | 28.62 |
| Alcohol (%E) | 0.08 | 4.40 |
| SFA (%E) | 13.37 | 5.76 |
| Monounsaturated fatty acids (MUFA) (%E) | 10.41 | 15.66 |
| PUFA (%E) | 4.81 | 4.97 |
| SFA 16:0 (palmitic acid) (G) | 17.84 | 11.28 |
| MUFA 18:1 (oleic acid) (G) | 27.35 | 43.02 |
| PUFA 20:4 (arachidonic acid [AA]) (G) | 0.13 | 0.15 |
| PUFA 20:5 (eicosapentaenoic acid [EPA]) (G) | 0.01 | 0.12 |
| PUFA 22:5 (docosapentaenoic acid [DPA]) (G) | 0.01 | 0.04 |
| PUFA 22:6 (docosahexaenoic acid [DHA]) (G) | 0.06 | 0.27 |
| PUFA/SFA ratio | 0.36 | 0.88 |
| Total dietary fiber (G) | 21.60 | 48.57 |
| Sodium (MG) | 3626.2 | 2738.7 |
| Calcium (MG) | 1023.0 | 1242.1 |
| Vitamin D (MCG) | 5.8 | 6.3 |
Aerobic measurements after CanDiet and MedDiet.
| CanDiet ± SD (n = 7) | Range | MedDiet ± SD (n = 7) | Range | |
|---|---|---|---|---|
| Mean exercise time (minutes) | 10.9 ± 5.1 | 4–20 | 11.4 ± 5.1 | 4–20 |
| Mean exercise HR (bpm) | 164 ± 8 | 154–177 | 168 ± 9 | 158–181 |
| Estimated max HR (bpm) | 195 ± 5 | 188–201 | 195 ± 5 | 188–201 |
| Maximal HR (bpm) | 191 ± 6 | 182–201 | 190 ± 5 | 182–200 |
| % of estimated max HR achieved | 98 ± 2.7 | 95–102 | 98 ± 2.4 | 95–101 |
| HR recovery 5 min post-test (%) | − 50.5 ± 3.5 | − 57.29/− 46.56 | − 51.9 ± 4.0 | − 57.89/− 45.21 |
| Estimated mean VO2 max (ml/min/kg) | 43.5 ± 9.0 | 31.5–59.5 | 44.5 ± 9.0 | 31.5- 59.5 |
| Borg rating of perceived exertion (RPE) | 8.9 ± 0.7 | 8–10 | 9.3 ± 0.5 | 9–10 |
Figure 2Response curves of eCBome mediators and precursors (fmol/μl) to maximal aerobic test according to the diet. Panels show results for (A) N-acylethanolamines, (B) monoacylglycerols and (C) polyunsaturated fatty acids. The graph represents the mean with the standard error of the plasmatic concentrations of these lipids at each time point for the two diets. Tpre corresponds to the initial concentration before the aerobic test, T0 corresponds to the immediate end of the aerobic test and T15, T30, T45 and T60 correspond to the recovery phase. Lipid concentrations have been normalized using ranked values fitted into mixed linear-effect models (LME) and differences between diets and times have been tested by analysis of variance (ANOVA). For difference between diets, significance was set at p < 0.1 (.), p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). For difference between times, indicated by bold blue line, significance was set at p < 0.1 (a), p < 0.05 (b), p < 0.01 (c), p < 0.001 (d). N = 7 per diet. Names of the molecules are anandamide (AEA), N-palmitoylethanolamine (PEA), N-oleoylethanolamine (OEA), Nlinoleoylethanolamine (LEA), N-stearoylethanolamine (SEA), Ndocosapentaenoylethanolamine (DPEA), Neicosapentaenoylethanolamine (EPEA), Ndocosahexaenoyl‑ethanolamine (DHEA), 1- plus 2-arachidonoyl-glycerol (2-AG), 1- plus 2-palmitoyl-glycerol (2-PG), 1- plus 2-oleoyl-glycerol (2-OG), linoleoyl-glycerol (2-LG), 1- plus 2-eicosapentaenoyl-glycerol (2-EPG), 1- plus 2-docosaepentaenoic-glycerol (2-DPG), 1- plus 2-docosahexaenoyl-glycerol (2-DHG), arachidonic acid (AA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA).
Figure 3Response curves of SCFA to maximal aerobic test according to the diet. The graph represents the means with the standard errors of the plasmatic SCFA concentrations at each time point for the two diets. Tpre corresponds to the initial concentration before the aerobic test, T0 corresponds to the immediate end of the aerobic test and T15, T30, T45 and T60 correspond to the recovery phase. SCFA concentrations have been normalized using ranked values fitted into mixed linear-effect models (LME) and differences between diets and times have been tested by analysis of variance (ANOVA). For difference between diets, significance was set at p < 0.1 (.), p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). For difference between times, indicated by bold blue line, significance was set at p < 0.1 (a), p < 0.05 (b), p < 0.01 (c), p < 0.001 (d). N = 7 per diet.
Figure 4Representation of plasmatic lipid mediators and SCFA profiles shows an effect of diet and time post-exercise on the endocannabinoidome. Principal component analysis (PCA) of plasmatic profiles of free n-3 PUFA, endocannabinoids and endocannabinoid-like mediators and SCFA, where ellipses show how these metabolites differentiate (A) diet, (B) time points and (C) visits. (D) Loading plot shows the influence of plasmatic lipids on the PCA plot. P-values on PCA were obtained by permutational multivariate analysis of variance (PERMANOVA).
Figure 5Multiple factor analysis (MFA) of the gut microbiota profile. Ellipses show the effect of (A) diet and (B) visit on individuals at different time points. (C) Loading plot shows the influence of the top 30 microbiota taxa with the highest contribution on the MFA plot. P-values on MFA were obtained by permutational multivariate analysis of variance (PERMANOVA). (D) Barplot representing the relative abundance of the 18 more abundant gut microbiota’s families. Dendrogram showing hierarchical clustering on Canberra distance between samples is printed above the barplot and determines the sample order. (E) Relative abundance of bacterial families significantly different between diet. Relative abundance of microbiota taxa has been normalized using ranked values fitted into mixed linear-effect models (LME) and differences between diets have been tested by analysis of variance (ANOVA). Significance was set at p < 0.1 (.), p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***).